Cite
MLA Citation
Victor Moreno et al.. “370 Pharmacodynamic assessment of a novel FAP-targeted 4–1BB agonist, administered as single agent and in combination with atezolizumab to patients with advanced solid tumors.” Journal for immunotherapy of cancer, vol. 8, n.d., pp. A225–A226. http://access.bl.uk/ark:/81055/vdc_100144729544.0x000004